The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(4-chlorobenzyloxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine ID: ALA4760886
PubChem CID: 162658746
Max Phase: Preclinical
Molecular Formula: C20H22ClN5O
Molecular Weight: 383.88
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1OCc1ccc(Cl)cc1
Standard InChI: InChI=1S/C20H22ClN5O/c21-17-3-1-14(2-4-17)13-27-19-9-15(10-24-20(19)22)16-11-25-26(12-16)18-5-7-23-8-6-18/h1-4,9-12,18,23H,5-8,13H2,(H2,22,24)
Standard InChI Key: XKGOZZFXSKAQGO-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
30.3667 -25.2091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3656 -26.0286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0736 -26.4376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7833 -26.0281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7805 -25.2055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0718 -24.8002 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.6580 -26.4339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9117 -26.1010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7725 -27.4159 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.5719 -27.2465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4916 -26.4356 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.4929 -27.2528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2013 -27.6603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1980 -28.4748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9055 -28.8822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6135 -28.4725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6096 -27.6511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9015 -27.2474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4866 -24.7942 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.3582 -26.7032 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.5416 -26.6145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2133 -25.8651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4047 -25.7752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9183 -26.4323 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.2466 -27.1817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0611 -27.2740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3224 -28.8790 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 20 1 0
9 10 2 0
10 7 1 0
2 7 1 0
4 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
5 19 1 0
9 20 1 0
21 22 1 0
21 26 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
20 21 1 0
16 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 383.88Molecular Weight (Monoisotopic): 383.1513AlogP: 3.68#Rotatable Bonds: 5Polar Surface Area: 77.99Molecular Species: BASEHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 10.12CX LogP: 2.41CX LogD: -0.21Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.70Np Likeness Score: -0.87
References 1. May-Dracka TL,Arduini R,Bertolotti-Ciarlet A,Bhisetti G,Brickelmaier M,Cahir-McFarland E,Enyedy I,Fontenot JD,Hesson T,Little K,Lyssikatos J,Marcotte D,McKee T,Murugan P,Patterson T,Peng H,Rushe M,Silvian L,Spilker K,Wu P,Xin Z,Burkly LC. (2018) Investigating small molecules to inhibit germinal center kinase-like kinase (GLK/MAP4K3) upstream of PKCθ phosphorylation: Potential therapy to modulate T cell dependent immunity., 28 (10): [PMID:29636220 ] [10.1016/j.bmcl.2018.03.032 ]